NPCE
Neuropace
$12.93
−$0.09 (−0.69%)Oct 28, 2026
Key metrics
The numbers that frame NPCE today
- Market cap
- $443.81M
- Gross margin
- 79.6%
- EV / Sales
- 5.1
- ROIC
- -9.3%
- Div yield
- 0%
- Debt / equity
- 5.9
- 52wk Low
- $9.22
- 52wk High
- $19.60
Growth
Revenue and earnings trend for NPCE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NPCE
Is Neuropace a good buy?
Yes. Neuropace has strong quality and mixed momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Neuropace is selling at a high price, which cuts against the buy case.
What is the market capitalization of NPCE?
Neuropace's market capitalization is $443.81M.
What is the 52-week high for NPCE stock?
The 52-week high for Neuropace is $19.60. The current close of $12.93 is 34% below that high.
What is the 52-week low for NPCE stock?
The 52-week low for Neuropace is $9.22. The current close of $12.93 is 40.2% above that low.
Does NPCE stock pay dividends?
Neuropace does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NPCE?
Neuropace's Debt / Equity ratio is 5.89.